Your search returned 75 studies. (Get alerts for new studies):
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Fergus Falls, Minnesota
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Fergus Falls, Minnesota
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Fergus Falls, Minnesota
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Fergus Falls, Minnesota
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Fergus Falls, Minnesota
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Fergus Falls, Minnesota
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Fergus Falls, Minnesota
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Fergus Falls, Minnesota
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Fergus Falls, Minnesota
- Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage II
Conditions: Head and Neck Cancer - Precancerous Condition
Location: Fergus Falls, Minnesota
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Fergus Falls, Minnesota
- LABS-3 Psychosocial
Conditions: Obesity - Depression
Location: Fargo, North Dakota
- Testing an Alternative Therapy for Bulimia Nervosa
Conditions: Eating Disorders
Location: Fargo, North Dakota
- Effects of Gastric Bypass on Blood Levels of Duloxetine
Conditions: Gastric Bypass
Location: Fargo, North Dakota
- Pramipexole for Binge Eating Disorder
Conditions: Binge Eating Disorder
Location: Fargo, North Dakota
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Fargo, North Dakota
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, North Dakota
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Fargo, North Dakota
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Fargo, North Dakota
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Fargo, North Dakota
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Fargo, North Dakota
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Fargo, North Dakota
- Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
Conditions: Roux en Y Gastric Bypass Surgery
Location: Fargo, North Dakota
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Diso
Conditions: Attention Deficit Hyperactivity Disorder
Location: Fargo, North Dakota
- Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Conditions: Multiple Sclerosis Relapse
Location: Fargo, North Dakota
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-re
Conditions: Herpes Zoster
Location: Fargo, North Dakota
- Efficacy and Safety Study of Methylphenidate Hydrochloride Modified Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (A
Conditions: Attention Deficit/Hyperactivity Disorder
Location: Fargo, North Dakota
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Breast Cancer
Location: Fargo, North Dakota
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Fargo, North Dakota
- A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squ
Conditions: Lung Cancer, Small Cell
Location: Fargo, North Dakota
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Fargo, North Dakota
- Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Fargo, North Dakota
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Fargo, North Dakota
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- Allopurinol Outcome Study
Conditions: Gout
Location: Fargo, North Dakota
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Fargo, North Dakota
- A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Conditions: Asthma
Location: South Fargo, North Dakota
- Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides
Conditions: Healthy
Location: Fargo, North Dakota
- A Study in Adults With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Fargo, North Dakota
- A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
Conditions: Healthy Volunteers - Atopic Dermatitis - Netherton Syndrome
Location: Fargo, North Dakota
- Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Fargo, North Dakota
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
Conditions: Major Depressive Disorder
Location: Fargo, North Dakota
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Fargo, North Dakota
- Open Label Study of Long Term Evaluation Against LDL-C Trial (OSLER)
Conditions: Hypercholesterolemia
Location: Fargo, North Dakota
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Conditions: Perennial Allergic Rhinitis - PAR
Location: Fargo, North Dakota
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
Conditions: Seasonal Allergic Rhinitis
Location: Fargo, North Dakota
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Bet
Conditions: Vaccines - Meningococcal Vaccines
Location: Fargo, North Dakota
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Bet
Conditions: Vaccines - Meningococcal Vaccines
Location: Fargo, North Dakota
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Betwe
Conditions: Vaccines - Meningococcal Vaccines
Location: Fargo, North Dakota
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Betwe
Conditions: Vaccines - Meningococcal Vaccines
Location: Fargo, North Dakota
- AMG 151 Amgen Protocol Number 20100761
Conditions: Diabetes Mellitus
Location: Fargo, North Dakota
- A Study in Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Fargo, North Dakota
- Effect of Teriparatide on Hip Fracture Healing
Conditions: Femur Neck Fracture
Location: Fargo, North Dakota
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Fargo, North Dakota
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Fargo, North Dakota
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, North Dakota
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, North Dakota
- Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
Conditions: Bursitis - Tendonitis - Shoulder Pain
Location: Fargo, North Dakota
- Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Conditions: Gout
Location: Fargo, North Dakota
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Conditions: Tophaceous Gout
Location: Fargo, North Dakota
- A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovasc
Conditions: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Location: Fargo, North Dakota
- Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
Conditions: Ebola Virus Infection
Location: Fargo, North Dakota
- Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Conditions: Drug Safety
Location: Fargo, North Dakota
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, North Dakota
- Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus
Location: Fargo, North Dakota
- Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Conditions: Postmenopausal Osteoporosis
Location: Fargo, North Dakota
- Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Conditions: Pain - Otitis Media
Location: Fargo, North Dakota
- Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Conditions: Pain - Otitis Media
Location: Fargo, North Dakota
|